BIO Web of Conferences · 2020 · 16 citations · 15 references
MedicineMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntifungal AgentsAntimicrobial TherapyAnti-biofilm StrategiesBiofilm InhibitionBiofilm InhibitorsBiofilm-disrupting AgentsChemical Inhibition Of BiofilmsEradicationInhibitors Of Biofilm FormationMinimum Biofilm Eradication Concentration
Curcumin is a polyphenol compound that is a member of the ginger family (Zingiberaceae), which has potential as an antibacterial, antifungal, and polymicrobial antibiofilm on the catheter. Still, its inhibitory activity and eradication of non-catheter polymicrobial antibiotics against S. aureus, P. aeruginosa, E. coli , and C. albicans have never been reported. The discovery of a candidate polymicrobial anti-biofilm drug is indispensable for overcoming infections associated with biofilms. This study aims to determine the inhibitory activity and eradication of curcumin on polymicrobial biofilms. Inhibition testing and eradication activity of polymicrobial biofilms were performed using the microtiter broth method. The effectiveness of curcumin on polymicrobial biofilms was analyzed using minimum biofilm inhibition concentration (MBIC50) and minimum biofilm eradication concentration (MBEC50). The mechanism of action of curcumin against polymicrobial biofilms is tested using scanning electron microscopy (SEM). Curcumin 1 % b/v gives biofilm inhibition activity in the mid-phase and maturation of 62.23 % ± 0.01, 59.43 % ± 0.01, and can eradicate polymicrobial biofilms by 55.79 % ± 0.01 and not much different with nystatin drug control activity. The results also provide evidence that curcumin can damage the extracellular polymeric matrix (EPS) polymicrobial biofilms of S. aureus , P. aeruginosa , E. coli , and C. albicans and damage the morphology of polymicrobial biofilms . Therefore, curcumin can be developed as a candidate for new antibiofilm drugs against polymicrobial biofilms S. aureus, P. aeruginosa, E. coli dan C albicabs.
15
Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections
Gregory G. Anderson, Joseph J. Palermo, Joel D. Schilling et al. · Science · 2003 · 1.2K citations
Life Sciences, Microbiology, Urology +17
Quorum sensing in <i>Pseudomonas aeruginosa</i> biofilms
Teresa R. de Kievit · Environmental Microbiology · 2008 · 420 citations · Full text
Melphine Harriott, Mairi C. Noverr · Antimicrobial Agents and Chemotherapy · 2010 · 168 citations · Full text